Cardiac transplant vasculopathy

Area of Science:

• Cardiology
• Immunology
• Transplantation

Background:

• Transplant vasculopathy is a chronic rejection process impacting graft survival.
• Interventional cardiologists manage this condition using percutaneous coronary intervention (PCI).

Discussion:

• Everolimus drug-eluting stents (DES) are utilized to treat transplant vasculopathy.
• While effective in reducing in-stent restenosis, these stents do not halt the diffuse progression of the disease.

Key Insights:

• PCI with everolimus DES is a current strategy for managing transplant vasculopathy.
• Transplant vasculopathy exhibits diffuse progression, indicating limitations of current stent-based therapies.

Outlook:

• Further research is needed to address the diffuse nature of transplant vasculopathy.
• Novel therapeutic strategies beyond current stenting approaches may be required for long-term graft maintenance.